Beranda524663 • BOM
add
Bharat Immunologicals&Biologcls Corp Ltd
Tutup sebelumnya
₹22,12
Rentang hari
₹22,02 - ₹22,93
Rentang tahun
₹19,00 - ₹35,88
Kapitalisasi pasar
964,64 jt INR
Volume Rata-Rata
59,90 rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
BOM
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (INR) | Sep 2023info | Perubahan Y/Y |
|---|---|---|
Pendapatan | — | — |
Biaya operasional | 47,23 jt | — |
Laba bersih | -49,18 jt | — |
Margin laba bersih | — | — |
Penghasilan per saham | — | — |
EBITDA | -46,86 jt | — |
Tarif pajak efektif | 26,00% | — |
Neraca
Total aset
Total liabilitas
| (INR) | Sep 2023info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 89,09 jt | — |
Total aset | 1,88 M | — |
Total liabilitas | 1,09 M | — |
Total ekuitas | 787,09 jt | — |
Saham yang beredar | 43,14 jt | — |
Harga terhadap nilai buku | 1,21 | — |
Tingkat pengembalian aset | — | — |
Tingkat pengembalian modal | -7,59% | — |
Arus Kas
Perubahan kas bersih
| (INR) | Sep 2023info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -49,18 jt | — |
Kas dari operasi | — | — |
Kas dari investasi | — | — |
Kas dari pembiayaan | — | — |
Perubahan kas bersih | — | — |
Arus kas bebas | — | — |
Tentang
Bharat Immunologicals and Biologicals Corporation Limited is a Public Sector Undertaking of the Government of India. Established in 1989 in Bulandshahar, Uttar Pradesh, BIBCOL manufactures oral polio vaccines and other immunisers. The company formulates over 12.5 crore doses of OPV and had aggregated revenues of ₹30.5 crore in fiscal 2006.
BIBCOL is under the administrative control of the Department of Biotechnology, Ministry of Science and Technology. Wikipedia
Didirikan
1989
